Australia markets close in 3 hours 48 minutes

GlaxoSmithKline plc (GLAXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
19.99+0.72 (+3.74%)
At close: 2:29PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts441616
Avg. Estimate28.4623.49101.23111.68
Low estimate25.818.793.81103.53
High estimate30.328.47105116.5
Year ago EPS35.623.3115.9101.23
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts441716
Avg. Estimate11.88B12.19B45.82B48.06B
Low estimate11.77B12.02B44.78B46.68B
High estimate11.97B12.32B47.18B49.84B
Year ago sales11.88B12.16B47.44B45.82B
Sales growth (year/est)-0.00%0.30%-3.40%4.90%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS30.4323.1522.5320.07
Actual EPS35.623.322.928.1
Difference5.170.150.378.03
Surprise %17.00%0.60%1.60%40.00%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate28.4623.49101.23111.68
7 days ago28.4623.49101.23111.55
30 days ago29.5625.09100.07110.9
60 days ago28.6823.7697.77109.34
90 days ago29.6323.697108.4
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/A22
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesGLAXFIndustrySector(s)S&P 500
Current qtr.-20.10%N/AN/AN/A
Next qtr.0.80%N/AN/AN/A
Current year-12.70%N/AN/AN/A
Next year10.30%N/AN/AN/A
Next 5 years (per annum)3.63%N/AN/AN/A
Past 5 years (per annum)11.53%N/AN/AN/A